1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase

被引:175
作者
Perry, PJ
Gowan, SM
Reszka, AP
Polucci, P
Jenkins, TC
Kelland, LR
Neidle, S
机构
[1] Inst Canc Res, Canc Res Campaign, Biomol Struct Unit, Sutton SM2 5NG, Surrey, England
[2] Inst Canc Res, Ctr Canc Therapeut, Canc Res Campaign, Sutton SM2 5NG, Surrey, England
[3] Univ Camerino, Dept Chem, I-62032 Camerino, Italy
关键词
D O I
10.1021/jm9801105
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A number of 1,4- and 2,6-difunctionalized amidoanthracene-9, l0-diones have been prepared. We have examined their in vitro cytotoxicity in several tumor cell lines and their ability to inhibit the telomere-addition function of the human telomerase enzyme together with their inhibition of the Taq polymerase enzyme. Compounds with -(CH2)(2)- side chains terminating in basic groups such as piperidine show inhibition of telomerase at (IC50)-I-tel levels of 4-11 mu M. These are thus among the most potent nonnucleoside telomerase inhibitors reported to date. Cytotoxicity levels in human tumor cell lines were at comparable levels for several compounds. Implications for amidoanthracene-9,10-dione telomerase inhibitors as potential anticancer agents are discussed.
引用
收藏
页码:3253 / 3260
页数:8
相关论文
共 41 条
[1]   ANTHRACENE-9,10-DIONES AS POTENTIAL ANTICANCER AGENTS - SYNTHESIS, DNA-BINDING, AND BIOLOGICAL STUDIES ON A SERIES OF 2,6-DISUBSTITUTED DERIVATIVES [J].
AGBANDJE, M ;
JENKINS, TC ;
MCKENNA, R ;
RESZKA, AP ;
NEIDLE, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (08) :1418-1429
[2]   EVIDENCE FOR A CRITICAL TELOMERE LENGTH IN SENESCENT HUMAN FIBROBLASTS [J].
ALLSOPP, RC ;
HARLEY, CB .
EXPERIMENTAL CELL RESEARCH, 1995, 219 (01) :130-136
[3]   Porphyrin binding to quadruplexed T4G4 [J].
Anantha, NV ;
Azam, M ;
Sheardy, RD .
BIOCHEMISTRY, 1998, 37 (09) :2709-2714
[4]   STRUCTURE AND FUNCTION OF TELOMERES [J].
BLACKBURN, EH .
NATURE, 1991, 350 (6319) :569-573
[5]   Telomere shortening and tumor formation by mouse cells lacking telomerase RNA [J].
Blasco, MA ;
Lee, HW ;
Hande, MP ;
Samper, E ;
Lansdorp, PM ;
DePinho, RA ;
Greider, CW .
CELL, 1997, 91 (01) :25-34
[6]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[7]   Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines [J].
Bryan, TM ;
Englezou, A ;
DallaPozza, L ;
Dunham, MA ;
Reddel, RR .
NATURE MEDICINE, 1997, 3 (11) :1271-1274
[8]   Telomerase activity and survival of patients with node-positive breast cancer [J].
Clark, GM ;
Osborne, CK ;
Levitt, D ;
Wu, F ;
Kim, NW .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (24) :1874-1881
[9]   SYNTHESIS, MOLECULAR MODELING, DNA-BINDING, AND ANTITUMOR PROPERTIES OF SOME SUBSTITUTED AMIDOANTHRAQUINONES [J].
COLLIER, DA ;
NEIDLE, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (04) :847-857
[10]   TELOMERASE ACTIVITY IN HUMAN OVARIAN-CARCINOMA [J].
COUNTER, CM ;
HIRTE, HW ;
BACCHETTI, S ;
HARLEY, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :2900-2904